… release syndrome-like (CRSL) features. Therefore, we defined this … as COVID-19
infection-related CRSL. Our results found that IL-6 was a early indicators of CRSL in COVID-19-infected …

… in the midst of a volatile coronavirus disease 2019 (COVID-19) pandemic, antiviral and …
COVID-19 disease severity is hypothesized to result from cytokine release syndrome (CRS), …

… in severe COVID-19 profoundly impacts our understanding of the disease and impacts
on therapeutic strategies. We therefore screened all consecutive 19 severe COVID-19-patients, …

… Covid-19 who despite improvement in his respiratory symptoms developed a mild to moderate
cytokine release syndrome … ferritin, D-dimer, and IL-6 levels normalized. To our knowledge…

… Cytokine-release syndrome (CRS) in COVID-19 patients can cause multiorgan failure and
… We used a structured protocol based on clinical, biochemical, and interleukin 6 (IL-6) criteria …

… Late-onset severe COVID-19 patients may respond to anti-… of 15 COVID-19 patients admitted
to ICU who received corticosteroids in the context of CRS. Cytokine release syndrome was …

… COVID-19 relates to the clinical and analytical characteristics observed in cytokine release
syndrome (… That is why several authors have proposed the blocking of IL-6 as adjunct therapy …

… A novel coronavirus pneumonia (COVID-19) has caused … COVID-19 is known to cause a
cytokine release syndrome (CRS) like response, and interleukin-6 (IL-6) is one of the cytokines …

… coronavirus disease 2019 (COVID-19) vaccination programs globally, which includes
administration of mRNA vaccines. Cytokine release syndrome … BioNTech mRNA COVID-19 …

… Evidence from case reports and observational cohort studies suggested that patients
admitted to hospital with COVID-19 pneumonia and cytokine release syndrome treated with …